Baker Bros. Advisors
$17.3B Assets Reported
92 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| INCY | Incyte Corporation | 30,744,412 | $2.9B | 16.7% |
| ONC | BeOne Medicines Ltd. | 8,799,053 | $2.6B | 15.1% |
| INSM | Insmed Incorporated | 7,421,111 | $1.2B | 7.0% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 2,141,701 | $1.1B | 6.5% |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,896,690 | $955M | 5.5% |
| RVMD | Revolution Medicines, Inc. | 9,555,357 | $929M | 5.4% |
| CELC | Celcuity Inc. | 7,915,792 | $904M | 5.2% |
| KOD | Kodiak Sciences Inc. | 19,919,186 | $759M | 4.4% |
| KYMR | Kymera Therapeutics, Inc. | 8,657,242 | $721M | 4.2% |
| SMMT | Summit Therapeutics Inc. | 36,391,063 | $690M | 4.0% |
Track Baker Bros. Advisors's 13F portfolio: $17.3B in reported holdings, 92 positions. Top holdings, AUM, and quarterly changes on SentiSense.